Patents by Inventor Miguel José Maldonado López

Miguel José Maldonado López has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-invasive sensor for determining functional characteristics of the cornea, device including said sensor and use thereof
    Patent number: 8948840
    Abstract: The present invention relates to a sensor and device incorporating said sensor for obtaining data useful to determine the functional characteristics of the cornea in a non-invasive manner, particularly for establishing a correlation between the impedance at different frequencies and the permeability of the endothelium and epithelium and stromal hydration level.
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: February 3, 2015
    Assignees: Consejo Superior de Investigaciones Cientificas, Universidad de Valladolid
    Inventors: Antón Guimera Brunet, Rosa Villa Sanz, Gemma Gabriel Buguña, Miguel José Maldonado López
  • NON-INVASIVE SENSOR FOR DETERMINING FUNCTIONAL CHARACTERISTICS OF THE CORNEA, DEVICE INCLUDING SAID SENSOR AND USE THEREOF
    Publication number: 20130012803
    Abstract: The present invention relates to a sensor and device incorporating said sensor for obtaining data useful to determine the functional characteristics of the cornea in a non-invasive manner, particularly for establishing a correlation between the impedance at different frequencies and the permeability of the endothelium and epithelium and stromal hydration level.
    Type: Application
    Filed: February 28, 2011
    Publication date: January 10, 2013
    Inventors: Antón Guimera Brunet, Rosa Villa Sanz, Gemma Gabriel Buguña, Miguel José Maldonado López
  • USE OF TRANSFORMING GROWTH FACTOR - BETA 1 (TGF-B1) INHIBITOR PEPTIDES FOR THE TREATMENT OF CORNEAL FIBROSIS AND/OR HAZE
    Publication number: 20120315256
    Abstract: The invention refers to the use of transforming growth factor-beta 1 (TGF-?1) inhibitor peptides or polynucleotides encoding said peptides for the prevention and/or treatment of corneal fibrosis and/or corneal haze.
    Type: Application
    Filed: February 21, 2011
    Publication date: December 13, 2012
    Applicants: DIGNA BIOTECH, S.I., PROYECTO DE BIOMEDICINA CIMA S.L.
    Inventors: Javier Dotor De Las Herrerias, Miguel Jose Maldonado Lopez